Concepedia

Publication | Open Access

Phase I Study of Samarium-153 Lexidronam With Docetaxel in Castration-Resistant Metastatic Prostate Cancer

DOIFull Paper Access

99

Citations

10

References

2009

Year

Michael J. Morris, Neeta Pandit‐Taskar, Jorge A. Carrasquillo, Chaitanya Divgi, Susan F. Slovin, William Kevin Kelly, Dana E. Rathkopf, Gretchen A. Gignac, David B. Solit, Lawrence H. Schwartz,
Journal of Clinical Oncology

Abstract

Docetaxel and (153)Sm-EDTMP can be combined safely at full doses over repeated cycles. Responses were seen in the small group of patients with taxane-resistant disease tested. The optimal phase II doses for patients with taxane-naïve disease may differ from those optimal for patients with taxane-resistant disease.

References

YearCitations

Page 1